• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Calcium metabolism in multiple myeloma.

作者信息

Vigo P L, Corghi E, Mozzana R, Girardello R, Soldati L, Saviano S, Polli E E, Milhaud G

出版信息

Biomed Pharmacother. 1982;36(5):240-5.

PMID:7168801
Abstract

45Calcium metabolism and circulating levels of iPTH (N-terminal fragment) and iCT were investigated in normocalcemic patients with multiple myeloma (12) in an attempt to ascertain early changes in calcium metabolism, which may occur before hypercalcemia develops. The same parameters were also investigated in patients with senile osteoporosis (11), corticosteroid-induced osteoporosis (6), Paget's disease (6) and controls without bone disorders (13). In the myeloma group, the exchangeable calcium pool (7,678 +/- 321 mg) was significantly higher (P less than 0.01) than in the control group (4,405 +/- 374 mg), the senile osteoporosis group (4,108 +/- 407 mg) and the corticosteroid-induced osteoporosis group (3,015 +/- 161 mg) and nearly as high as in the Paget's disease group (8,876 +/- 1,173 mg). Calcium pool turnover rate was higher in the myeloma group than in controls, as were bone anabolism and bone catabolism, although differences were not statistically significant. There were no statistically significant differences among the groups in the plasma iPTH or iCT, although the mean value of the latter was higher in the myeloma group than in controls (86 +/- 24 vs. 47 +/- 13 pg/ml). These data suggest that an increase in the exchangeable calcium pool and in turnover rate may occur early in the course of multiple myeloma, preceding the development of hypercalcemia. The role of some homeostatic mechanisms in maintaining normal plasma calcium levels in multiple myeloma despite increased bone calcium resorption is discussed.

摘要

相似文献

1
Calcium metabolism in multiple myeloma.
Biomed Pharmacother. 1982;36(5):240-5.
2
Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.降低透析液钙浓度对血液透析患者血清骨转换标志物的影响。
Bone. 2005 May;36(5):909-16. doi: 10.1016/j.bone.2005.02.008. Epub 2005 Mar 24.
3
[Calcium-phosphorus metabolism and calcitrophic hormones in patients with active acromegaly with and without osteoporosis].[伴有和不伴有骨质疏松症的活动性肢端肥大症患者的钙磷代谢及钙调节激素]
Vutr Boles. 1990;29(2):74-81.
4
Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.恶性肿瘤相关性高钙血症:一项关于临床特征以及循环钙水平、甲状旁腺激素和甲状旁腺激素相关肽之间关系的研究。
J Med Assoc Thai. 2007 Apr;90(4):663-71.
5
[Effectiveness of synthetic calcitonin derivative (elcatonin) on the bone pain and serum calcium concentration in multiple myeloma].
Gan To Kagaku Ryoho. 1990 May;17(5):1059-63.
6
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
7
An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.在一项利用周期性甲状旁腺激素和降钙素治疗骨质疏松症的方案中,对几种骨形成和骨吸收生化标志物的评估。
J Clin Invest. 1993 Mar;91(3):1138-48. doi: 10.1172/JCI116273.
8
[Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].氟达拉滨、米托蒽醌和地塞米松治疗难治性或复发性多发性骨髓瘤的初步报告
Ai Zheng. 2005 Dec;24(12):1518-21.
9
[Effect of clodronate in patients with multiple myeloma. Evaluation of specific markers of bone resorption].[氯膦酸盐对多发性骨髓瘤患者的影响。骨吸收特异性标志物的评估]
Cas Lek Cesk. 1997 Jan 22;136(2):57-60.
10
[Serum osteocalcin in children with chronic renal insufficiency].[慢性肾功能不全患儿的血清骨钙素]
Srp Arh Celok Lek. 1996 Sep-Oct;124(9-10):227-31.